More importantly, by combining the outcomes of the PPI network, GO and KEGG analysis, we speculated that FTA could ameliorate cholestasis by acting on important targets such as TRL4, MYD88, NF-KB1, and MMP-2. The gene discussed is NFKB1; the disease is cholestasis.